Blue Cloud Softech Solutions Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 14 Jun 2026 | IT - Software | Market Cap: ₹2.1K Cr
The company targets revenue of Rs. Revenue is projected to reach Rs.
From Blue Cloud Softech Solutions Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹22.2
Market Cap
₹2.1K Cr
P/E Ratio
32.5
Revenue Rank
Rank 2
Margin Rank
Rank 2
How does Blue Cloud Softech Solutions Ltd rank in IT - Software?
Compare Blue Cloud Softech Solutions Ltd against every IT - Software company this quarter on revenue, margins and earnings-call signals.
Revenue: Rank 2Margin: Rank 2
Blue Cloud Softech Solutions Ltd — Quarterly revenue & net profit
Revenue Net Profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Reported quarterly figures (₹ Cr). Latest: revenue ₹265 Cr, net profit ₹19 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →The company targets revenue of Rs. 3,000 crores by FY27, growing from current run rates of Rs. 200-250 crores per quarter to about Rs. 700+ crores per quarter by then.
- →Post-FY27, management expects a year-on-year growth of around 25% to 35%, with a confidence level of approximately 30% CAGR.
- →Growth drivers include long-term contracts, expansion in AI-first cybersecurity solutions, sovereign data centers, healthcare, enterprise applications, and international market penetration.
- →Both organic growth and inorganic through acquisitions (like Global Impx) will contribute to increased order books and revenues.
- →Revenues from AIS Anywhere are expected to grow through transitioning from customized delivery to SaaS models, enabling scale across multiple clients.
- →The company anticipates sustained gross margins and EBITDA margins in the 10%-15% range while scaling revenue.
📈 Profitability & Margins
Rank 2- →Revenue is projected to reach Rs. 3,000 crores by FY27, with a stable Q1 run-rate of around Rs. 200-250 crores currently, expected to rise toward Rs. 700 crores per quarter as orders convert and new contracts close.
- →Organic and inorganic growth (including acquisitions like Global Impx) will contribute to revenue increases.
- →EBITDA margins are expected to stabilize in the 10%-15% range, with recent quarters showing improvements up to 20%.
- →Gross margins are projected to improve by 5%-6% over current levels, though crossing 50% is unlikely.
- →R&D expenses will focus more on productization and Continuous Integration/Continuous Deployment models, with reduced incremental R&D spend compared to previous years.
- →Employee headcount will remain steady or slightly increase due to government PPP projects and AI customizations.
- →Beyond FY27, a steady growth rate of around 25%-30% year-on-year is anticipated for revenues and profits.
🏗️ Capital Expenditure Plans
Yes- →The company is targeting CAPEX of Rs. 150 crores to Rs. 200 crores as a minimum budget for the current year, with a possibility of increase depending on project rollouts.
- →CAPEX will be used for projects such as Captive Non-Public Network (CNPN) telecom infrastructure and private mobile networks.
- →There are plans for phased development of sovereign data centers, with the first line expected to be ready by Q1 of 2027.
- →The data centers will help reduce recurring cloud service costs (currently 15%-35% of expenses) and improve margins.
- →The company acquired BluBio sciences SPV with 25% ownership, which involves AI healthcare platform technology integration but currently not consolidated in revenue.
- →Also, the company received in-principle approval for acquiring Global Impx, which has a strong order book in the EV and renewable energy sector, expected to contribute to revenue growth.
💰 Fundraising & Capital Structure
No information- →The transcript does not explicitly mention any ongoing or planned fundraising through debt or equity.
- →CAPEX budget is mentioned as Rs. 150-200 crores (possibly higher depending on project rollouts), but there is no direct comment on how this CAPEX will be financed.
- →The company references ongoing repayments related to past investments, indicating existing debt obligations are being managed from operational revenues.
- →No explicit indication of new fundraising through equity or debt is mentioned in the provided transcript pages.
- →The company is focusing on balancing CAPEX and operational costs to maintain sustainable growth and margins.
📋 Order Book & Pipeline
Yes- →Current confirmed order book is approximately Rs. 1,100 crores for the next financial year (FY27).
- →This order book mainly consists of long-term contracts, many spanning around 5 years, with some contracts extending till 2030.
- →The order book mix: ~46-47% from cybersecurity, ~24-26% enterprise applications, ~14% from healthcare, and the rest from consulting and IT.
- →Pending orders and pipeline: Several confirmed orders beyond the existing order book, including those in negotiation and MOU stages that contribute to the aspirational Rs. 3,000 crores revenue target in FY27.
- →The company expects to grow the order book with a combination of organic growth and inorganic acquisitions.
- →Additionally, new projects, especially in AI and government-led PPP models, contribute to the pending order pipeline.
Key Metrics
Revenue
Rank 2
Margin
Rank 2
Capex
Yes
Fundraise
No information
Order Book
Yes
Continue your research
What Blue Cloud Soft.'s management said in earlier quarters
Frequently Asked Questions
What were Blue Cloud Softech Solutions Ltd Q4 FY26 results?
The company targets revenue of Rs. Revenue is projected to reach Rs.
What is Blue Cloud Softech Solutions Ltd share price analysis?
Blue Cloud Softech Solutions Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 32.5 with a market cap of ₹2,084 Cr. Investors should review the full earnings analysis for detailed insights.
Is Blue Cloud Softech Solutions Ltd planning capital expenditure?
The company is targeting CAPEX of Rs.
Keep Blue Cloud Softech Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.